Professor Indicted for $16 Million NIH Grant Fraud in Alzheimer's Drug Research

Hoau-Yan Wang accused of fabricating data to secure federal funds for developing Alzheimer's treatment.

Federal grand jury charges Hoau-Yan Wang with major fraud, wire fraud, and making false statements.
Wang allegedly manipulated data in grant applications, securing $16 million from NIH between 2017 and 2021.
The fraudulent research supported early development of simufilam, an experimental Alzheimer's drug.
Cassava Sciences, the pharmaceutical company involved, denies Wang's involvement in later-stage trials.
Wang faces decades in prison if convicted on all charges.